Portfolio (Quarterly)
Guide ↗
ADAR1 Capital Management, LLC
· CIK 0001940272| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 141 | MSLE | SATELLOS BIOSCIENCE INC | Healthcare | 222,555.0 | $1.3M | 0.07% | NEW | — | $5.63 | +46.9% |
| 142 | QURE | UNIQURE NV | Healthcare | 76,206.0 | $1.2M | 0.07% | NEW | — | $16.35 | +153.0% |
| 143 | NVO | NOVO-NORDISK A S | Healthcare | 33,000.0 | $1.2M | 0.07% | NEW | — | $36.75 | +34.0% |
| 144 | — | PROMIS NEUROSCIENCES INC | — | 95,350.0 | $1.2M | 0.07% | NEW | — | $12.70 | — |
| 145 | LXRX | LEXICON PHARMACEUTICALS INC | Healthcare | 750,000.0 | $1.2M | 0.07% | NEW | — | $1.56 | +48.7% |
| 146 | SDGR | SCHRODINGER INC | Healthcare | 101,500.0 | $1.2M | 0.07% | NEW | — | $11.36 | +49.6% |
| 147 | KPTI CALL | KARYOPHARM THERAPEUTICS INC | Healthcare | 205,200.0 | $1.1M | 0.07% | NEW | — | $5.57 | +72.7% |
| 148 | XNCR | XENCOR INC | Healthcare | 93,665.0 | $1.1M | 0.07% | NEW | — | $12.06 | +23.5% |
| 149 | OABI | OMNIAB INC | Healthcare | 705,190.0 | $1.1M | 0.07% | NEW | — | $1.57 | +53.5% |
| 150 | FDMT | 4D MOLECULAR THERAPEUTICS IN | Healthcare | 116,712.0 | $1.1M | 0.06% | NEW | — | $9.31 | +36.6% |
| 151 | KROS | KEROS THERAPEUTICS INC | Healthcare | 97,318.0 | $1.1M | 0.06% | NEW | — | $11.04 | -0.1% |
| 152 | DAWN | DAY ONE BIOPHARMACEUTICALS I | Healthcare | 49,923.0 | $1.1M | 0.06% | NEW | — | $21.44 | +0.4% |
| 153 | BMY | BRISTOL-MYERS SQUIBB CO | Healthcare | 17,500.0 | $1.1M | 0.06% | NEW | — | $60.65 | -6.5% |
| 154 | TNGX | TANGO THERAPEUTICS INC | Healthcare | 50,000.0 | $1.0M | 0.06% | NEW | — | $20.92 | +43.1% |
| 155 | TNYA | TENAYA THERAPEUTICS INC | Healthcare | 1,507,800.0 | $1.0M | 0.06% | NEW | — | $0.69 | +25.0% |
| 156 | — | BEST SPAC I ACQUISITION CORP | — | 100,000.0 | $1.0M | 0.06% | NEW | — | $10.40 | — |
| 157 | MCK | MCKESSON CORP | Healthcare | 1,200.0 | $1.0M | 0.06% | NEW | — | $865.36 | -9.4% |
| 158 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 18,200.0 | $1.0M | 0.06% | NEW | — | $56.49 | +4.1% |
| 159 | — | ARROWHEAD PHARMACEUTICALS IN | — | 10,000.0 | $1.0M | 0.06% | NEW | — | $102.40 | — |
| 160 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 20,840.0 | $1.0M | 0.06% | NEW | — | $49.05 | +69.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
94.6%
Financial Services
4.9%
Real Estate
0.1%
Consumer Cyclical
0.1%
Technology
0.1%
Communication Services
0.1%
Industrials
0.1%
Basic Materials
0.1%